Search research articles

关于 JoVE

概览领导团队博客 JoVE 帮助中心

作者

出版流程编辑委员会范围与政策同行评审常见问题投稿

图书馆员

用户评价订阅访问资源图书馆顾问委员会常见问题

研究

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments 存档

教育

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual 教师资源中心教师网站

使用条款与条件

相关概念视频

Animal Mitochondrial Genetics

Animal Mitochondrial Genetics

Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...

Electron Transport Chain: Complex I and II

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...

Pharmacogenomics: Identification of New Drug Targets

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序

Same author

VQF-Based Decoupled Navigation Architecture for High-Curvature Maneuvering of Underwater Vehicles.

Sensors (Basel, Switzerland)·2026

Same author

Design and lmplementation of wheel-leg-paddle lntegrated structure amphibious robot.

Scientific reports·2025

Same author

Position and Attitude Control of Multi-Modal Underwater Robots Using an Improved LADRC Based on Sliding Mode Control.

Sensors (Basel, Switzerland)·2025

Same author

Third party interventions promote cooperation on the interdependent networks: A perspective based on prospect theory.

Chaos (Woodbury, N.Y.)·2024

Same author

[Surgical treatment of 402 consecutive cases for hilar cholangiocarcinoma: Chinese single center experience].

Zhonghua wai ke za zhi [Chinese journal of surgery]·2007

Same author

Highly convergent route to cyclopeptide alkaloids: total synthesis of ziziphine N.

Organic letters·2007

Search research articles

相关实验视频

Updated: May 10, 2026

Assessing Mitochondrial Function in Sciatic Nerve by High-Resolution Respirometry

Assessing Mitochondrial Function in Sciatic Nerve by High-Resolution Respirometry

Published on: May 5, 2022

针对PGAM5驱动的线粒体综合应激反应减缓了亚型中ALS进展的速度.

Zhilong Zheng¹, Wangju Yang¹, Zhen Chen¹

¹Department of Neurobiology, School of Basic Medical Sciences, Nanjing Medical University, Nanjing 211166, Jiangsu, China.

|March 12, 2026

概括

糖酸突变酶-5 (PGAM5) 被确定为肌缩性侧面硬化症 (ALS) 发病的关键驱动因素,激活线粒体综合应激反应. 抑制PGAM5显示出作为治疗策略的希望,用于各种ALS亚型.

关键词:

这就是ALS.这是NMJNMJ的意思.这是一个PGAM5PGAM5.这是一个VCPVCP.骨髓缩侧面硬化症 (ALS) 是一种线粒体的综合应激反应线粒体酸酶糖酸盐突变酶 5 这就是MTSRISR.神经肌肉结节是一个神经肌肉结节.含有瓦洛的蛋白质.

更多相关视频

Author Spotlight: Decoding Mitochondrial Aging

Author Spotlight: Decoding Mitochondrial Aging

Published on: June 30, 2023

Understanding the Changes in Mitochondrial Morphology through Dynamic and Three-dimensional Fluorescence Micrographs

Understanding the Changes in Mitochondrial Morphology through Dynamic and Three-dimensional Fluorescence Micrographs

Published on: August 15, 2025

相关实验视频

Last Updated: May 10, 2026

Assessing Mitochondrial Function in Sciatic Nerve by High-Resolution Respirometry

Assessing Mitochondrial Function in Sciatic Nerve by High-Resolution Respirometry

Published on: May 5, 2022

Author Spotlight: Decoding Mitochondrial Aging

Author Spotlight: Decoding Mitochondrial Aging

Published on: June 30, 2023

Understanding the Changes in Mitochondrial Morphology through Dynamic and Three-dimensional Fluorescence Micrographs

Understanding the Changes in Mitochondrial Morphology through Dynamic and Three-dimensional Fluorescence Micrographs

Published on: August 15, 2025

科学领域:

神经科学是一个神经科学.
分子生物学分子生物学
遗传学是一个遗传学.

背景情况:

肌缩性侧面硬化症 (ALS) 呈现出显著的遗传和临床异质性,使其潜在的致病机制的理解变得复杂.
调解ALS病变的融合分子途径仍然定义不佳,阻碍了广泛的治疗方法的开发.

研究的目的:

为了确定常见的分子媒介的肌缩性侧面硬化症 (ALS) 病原体.
研究糖酸突变酶-5 (PGAM5) 在ALS中的作用及其作为治疗点的潜力.

主要方法:

利用CRISPR-Cas9查来识别ALS发病过程中的关键蛋白质.
研究了PGAM5和金属酶OMA1之间的相互作用,包括酸化部位.
在患者样本,有机体和动物模型中评估了PGAM5水平.
使用选择性抑制剂 (TAT-PO1) 和药理学剂 (特尔米沙坦) 调节PGAM5活性.

主要成果:

糖酸突变酶-5 (PGAM5) 被确定为ALS发病的常见媒介.
PGAM5通过去化OMA1激活线粒体综合应激反应 (mtISR),从而导致神经肌肉连接中断和运动缺陷.
在零星ALS患者,ALS器官和ALS小鼠模型中,PGAM5水平升高.
抑制PGAM5-OMA1相互作用或PGAM5本身抑制了mtISR激活,改善了ALS表型.

结论:

PGAM5在肌缩侧面硬化症 (ALS) 中起到融合和可操作的治疗标作用.
针对PGAM5提供了一种潜在的策略,通过调节线粒体综合应激反应来解决ALS的各种亚型.